BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18082364)

  • 21. Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women.
    Salonia A; Nappi RE; Pontillo M; Daverio R; Smeraldi A; Briganti A; Fabbri F; Zanni G; Rigatti P; Montorsi F
    Horm Behav; 2005 Feb; 47(2):164-9. PubMed ID: 15664019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Women's soccer injuries in relation to the menstrual cycle and oral contraceptive use.
    Möller-Nielsen J; Hammar M
    Med Sci Sports Exerc; 1989 Apr; 21(2):126-9. PubMed ID: 2709976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex differences and hormonal influences on response to cold pressor pain in humans.
    Kowalczyk WJ; Evans SM; Bisaga AM; Sullivan MA; Comer SD
    J Pain; 2006 Mar; 7(3):151-60. PubMed ID: 16516820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms.
    Brown C; Ling F; Wan J
    J Reprod Med; 2002 Jan; 47(1):14-22. PubMed ID: 11838304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of sex, menstrual cycle phase, and monophasic oral contraceptive pill use on local and central arterial stiffness in young adults.
    Priest SE; Shenouda N; MacDonald MJ
    Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H357-H365. PubMed ID: 29677465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones].
    Farkas M
    Acta Pharm Hung; 1992; 62(1-2):17-30. PubMed ID: 1566635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral contraceptive pill containing drospirenone and the professional voice: an electrolaryngographic analysis.
    Lã FM; Howard DM; Ledger W; Davidson JW; Jones G
    Logoped Phoniatr Vocol; 2009; 34(1):11-9. PubMed ID: 19152176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of resting state networks in the female brain during hormonal changes and their relation to premenstrual symptoms.
    De Bondt T; Smeets D; Pullens P; Van Hecke W; Jacquemyn Y; Parizel PM
    Brain Res; 2015 Oct; 1624():275-285. PubMed ID: 26253822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premenstrual asthma: prevalence, cycle-to-cycle variability and relationship to oral contraceptive use and menstrual symptoms.
    Murphy VE; Gibson PG
    J Asthma; 2008 Oct; 45(8):696-704. PubMed ID: 18951263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum sialic acids in the normal menstrual cycle: a possible test for the prediction of ovulation.
    Naguib YA; Darwish NA; Nabil ; Shaarawy M; Nagui AR; Thabet S
    J Egypt Soc Obstet Gynecol; 1978 Jan; 4(1):37-48. PubMed ID: 12309831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in saccadic latencies over the human menstrual cycle.
    Brooker EJ; Barnes RJ; Walton EK; Wickramasinghe AH
    Percept Mot Skills; 2003 Jun; 96(3 Pt 2):1197-214. PubMed ID: 12929774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laryngeal aerodynamics associated with oral contraceptive use: preliminary findings.
    Gorham-Rowan M; Fowler L
    J Commun Disord; 2009; 42(6):408-13. PubMed ID: 19539303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Safety, efficacy and control of the menstrual cycle by a monophasic oral contraceptive containing 75 mcg of gestodene and 30 mcg of ethynyl estradiol].
    Alvarado Zaldivar G; Ruiz Astorga R; Arenas Arenas M; Solis Carrera L; Rueda Cisneros D; Vázquez Arreola I
    Ginecol Obstet Mex; 1993 Oct; 61():299-303. PubMed ID: 8270225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart rate variability across the menstrual cycle in young women taking oral contraceptives.
    Teixeira AL; Ramos PS; Vianna LC; Ricardo DR
    Psychophysiology; 2015 Nov; 52(11):1451-5. PubMed ID: 26332575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual sensitivity across the menstrual cycle.
    Eisner A; Burke SN; Toomey MD
    Vis Neurosci; 2004; 21(4):513-31. PubMed ID: 15579218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptoms across the menstrual cycle in women with irritable bowel syndrome.
    Heitkemper MM; Cain KC; Jarrett ME; Burr RL; Hertig V; Bond EF
    Am J Gastroenterol; 2003 Feb; 98(2):420-30. PubMed ID: 12591063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pain threshold in relation to sex hormones.
    Rao SS; Ranganekar AG; Saifi AQ
    Indian J Physiol Pharmacol; 1987; 31(4):250-4. PubMed ID: 3450630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in pure-tone thresholds and temporary threshold shifts as a function of menstrual cycle and oral contraceptives.
    Swanson SJ; Dengerink HA
    J Speech Hear Res; 1988 Dec; 31(4):569-74. PubMed ID: 3230886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.